MediPal Holdings Corporation

TSE:7459.T

2510 (JPY) • At close July 31, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 3,671,3283,558,7323,360,0083,290,9213,211,1733,253,1223,181,9353,146,3413,064,0413,028,2352,872,9132,947,7382,810,9142,750,2152,662,8872,545,9852,463,8072,255,0462,166,8461,921,7141,665,902
Cost of Revenue 3,429,0833,312,0773,135,7033,073,4762,996,9123,016,3822,949,4332,918,2412,845,0222,810,7382,671,1782,738,3802,608,7722,557,6472,474,7402,354,8942,276,5712,063,3921,978,6111,760,1121,528,097
Gross Profit 242,245246,655224,305217,445214,261236,740232,502228,100219,019217,497201,735209,358202,142192,568188,147191,091187,236191,654188,235161,602137,805
Gross Profit Ratio 0.0660.0690.0670.0660.0670.0730.0730.0720.0710.0720.070.0710.0720.070.0710.0750.0760.0850.0870.0840.083
Reseach & Development Expenses 0991103108106118000000000000000
General & Administrative Expenses 0164,212144,338140,870144,243152,205153,805154,428151,832150,038144,671149,31807,9027,9528,3517,4588,21013,0219,5496,868
Selling & Marketing Expenses 23,59320,47418,80518,61718,66518,93017,34716,15416,02114,53613,67713,85713,97814,57114,68814,64514,73413,417000
SG&A 23,593184,686163,143159,487162,908171,135171,152170,582167,853164,574158,348163,17513,97822,47322,64022,99622,19221,62713,0219,5496,868
Other Expenses 163,04113,64812,08212,22312,66512,37211,51913,25311,51110,63710,58811,517159,640149,205151,959149,662151,589142,077147,438131,445119,951
Operating Expenses 186,634199,325175,328171,818175,679183,625182,671183,835179,364175,211168,936174,692173,618171,678174,599172,658173,781163,704160,459140,994126,819
Operating Income 55,61147,33148,97245,62438,57653,10949,82744,26039,65042,28332,79534,66228,51920,89013,54818,43313,45527,95027,77620,60810,986
Operating Income Ratio 0.0150.0130.0150.0140.0120.0160.0160.0140.0130.0140.0110.0120.010.0080.0050.0070.0050.0120.0130.0110.007
Total Other Income Expenses Net 21,12327,41021,08911,66010,66122,42713,63419,20612,80312,52312,12813,84011,3834,913-4,910-9,7458,12815,1896,5639,5008,318
Income Before Tax 76,73474,74170,06157,28449,23775,53663,46163,46652,45354,80644,92348,50239,90225,8038,6388,68821,58343,13934,33930,10819,304
Income Before Tax Ratio 0.0210.0210.0210.0170.0150.0230.020.020.0170.0180.0160.0160.0140.0090.0030.0030.0090.0190.0160.0160.012
Income Tax Expense 25,20322,97321,73818,08715,62124,30618,03519,93016,11517,88315,82218,39717,25711,3765,4256,7299,07515,34515,2339,26610,502
Net Income 40,28041,47438,80629,42323,92637,96834,35934,78029,01130,77123,68725,48518,65511,6501,7041,95812,51027,79419,10520,8428,729
Net Income Ratio 0.0110.0120.0120.0090.0070.0120.0110.0110.0090.010.0080.0090.0070.0040.0010.0010.0050.0120.0090.0110.005
EPS 193.19195.83184.82140.13113.95175.8154.09154.13128.12135.89104.73112.7782.2449.67.278.3152.3119.282.8697.6445.9
EPS Diluted 193.19195.83179.12131.41106.8165.33145.15149.91128.12135.89104.73112.7782.2449.67.278.3152.22118.5382.2994.2243.52
EBITDA 95,16192,73163,62271,63864,07990,36077,56979,07766,55054,58445,12047,81053,03339,12923,35323,86229,70249,59440,96833,90020,536
EBITDA Ratio 0.0260.0260.0190.0220.020.0280.0240.0250.0220.0180.0160.0160.0190.0140.0090.0090.0120.0220.0190.0180.012